Navigation Links
Cellular Dynamics International and VivoMedica Launch the CARDIOTOX Consortium to Validate a Human Cardiac Model for Preclinical Cardiotoxicity Testing
Date:9/14/2009

tium/consortium.html" target="_new">http://www.vivomedica.com/consortium/consortium.html.

About Cellular Dynamics International, Inc.

Cellular Dynamics International, Inc. (CDI) is a leading developer of next-generation stem cell technologies for drug development and personalized medicine applications. CDI harnesses the power of pluripotent stem cells and their ability to differentiate into any cell type for world-class drug development tools. In addition, it is the leader in iPS technology, the production of pluripotent stem cell lines from adult tissue. CDI was founded in 2004 by Dr. James Thomson, a pioneer in human embryonic stem cell research at the University of Wisconsin-Madison, and Tactics II Ventures, a Wisconsin-based venture capital fund. CDI's facilities are located in Madison, Wisconsin. See www.cellulardynamics.com.

About VivoMedica

VivoMedica plc is a British company that delivers high value technology solutions to the global Pharmaceutical Industry. These specialist Pharma-Ware solutions are designed to improve the cost, efficiency and effectiveness of the complex processes involved in the discovery and development of drugs, and in their effective use in treatment pathways. VivoMedica identifies, licenses and develops technologies that support these crucial process developments, and integrates them into products and service offerings that address the challenging needs of the global healthcare market. VivoMedica's lead programme is developed from a suite of patented healthcare technologies licensed from QinetiQ, and provides innovative solutions in the field of cardiotoxicity testing in drug development (DrugPrint(R)). VivoMedica is based at the Ken
'/>"/>

SOURCE Cellular Dynamics International (CDI)
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology
2. Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
3. Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma
4. Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics
5. Novel Photoconductive Life Science Research Innovation Enables Rapid, Reproducible, and Non-Invasive Cellular Excitation
6. Molecular Discoveries Shed Light on Liver Cancer -- Hepatocellular Carcinoma (HCC)
7. Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007
8. Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722
9. Pre-Clinical Data Show Intracellular Pathways Affected by ONCONASE(R)
10. Intra-Cellular Therapies Presents Data on Its Schizophrenia and Cognition in Schizophrenia Programs at the 14th Biennial Winter Workshop on Schizophrenia and Bipolar Disorders
11. Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--...mpanyfocusedondevelopingandcommercializingnovelpai...fJohnA.OrwintoitsBoardofDirectors,effectiveNovembe...ninthebiopharmaceuticalindustryandhasbeeninstrumen..., Mr.OrwincurrentlyservesasSeniorVicePresident,Bio...
(Date:11/23/2009)..., CINCINNATI,Nov.23/PRNewswire-FirstCall/--Healt...U.S.mail-orderpharmacy,todayannounceditsfinancialr...ompanyreportedquarterlyrevenueof$1,006,721,drivenb...s.Grossmarginsincreased13.0%year-over-yearto34.6%a...lossof$186,299forthethreemonthsendedSeptember30,20...
(Date:11/23/2009)..., CHICAGO,Nov.23/PRNewswire/--TwooftheChicagoare...ntroducinganewerainwomen,sbreastimaging,couplingth...nddiagnosticultrasoundwiththeabilitytohavethefullr...dwiththepatientbeforesheleavestheoffice.Drs.AhmedF...approach,withoutthecurrent6-9monthwaitforanappoint...
Breaking Medicine Technology:NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 2NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 3HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 2HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 3GenVec Announces Second Quarter 2009 Results Conference Call 53211 1GenVec Announces Second Quarter 2009 Results Conference Call 53211 2Cornerstone Therapeutics Announces Closing of Chiesi Transaction 13282 1Cornerstone Therapeutics Announces Closing of Chiesi Transaction 13282 2Cornerstone Therapeutics Announces Closing of Chiesi Transaction 13282 3Cornerstone Therapeutics Announces Closing of Chiesi Transaction 13282 4Cornerstone Therapeutics Announces Closing of Chiesi Transaction 13282 5Cornerstone Therapeutics Announces Closing of Chiesi Transaction 13282 6Infants Cared for in Another Home Become Heavier Toddlers 53209 1Infants Cared for in Another Home Become Heavier Toddlers 53209 2Infants Cared for in Another Home Become Heavier Toddlers 53209 3
...rstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP ...easures against biological and chemical threats, a...e call for investors on Wednesday, April 29th begi...ts rPA anthrax vaccine program. , , The dial-in ...The dial-in number for international callers is 85...
...r Altered Early Neural Development- , , PHILADELP...of the intricate pieces of the autism puzzle, with...ntributions to the disorder. One study pinpoints a...rcent of autism cases, while another study identif...wo crucial gene pathways. Significantly, both stud...
Other Medicine Technology:PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program 2Autism Genes Discovered; Help Shape Connections Among Brain Cells 2Autism Genes Discovered; Help Shape Connections Among Brain Cells 3Autism Genes Discovered; Help Shape Connections Among Brain Cells 4Autism Genes Discovered; Help Shape Connections Among Brain Cells 5Autism Genes Discovered; Help Shape Connections Among Brain Cells 6
(Date:11/24/2009)...24/PRNewswire-FirstCall/-HardtoTreatDiseases(HTDS;...diarySlavicaBioChem,isprovidingthisbriefupdatetoit...uediligencewiththeEUstemcellcompanyandmergerdiscus...tOct29,2009whichthecompanymade. http://www.pinkshe... ,, HTDSandSlavicaBiochemarealsodiscussingonexp...
(Date:11/24/2009)...swire-USNewswire/--Thereisanewgameintownwhenitcome...feringpragmaticandrealisticstrategieswheretraditio...ingthismovementisagroupcalledHAMS--HarmReduction,A...f-charge,lay-ledsupportandinformationalgroupforpeo...coholAbuseandAlcoholismtellsusthatonly7%ofpeoplewi...
(Date:11/24/2009)...swire/--TheGuardianLifeInsuranceCompanyofAmerica(G...ingproviderofemployeebenefitsforsmallandmid-sizedc...ofollowitscurrentinsurancecoverageguidelinesformam...htheAmericanCancerSocietyandAmericanMedicalAssocia...,, Recently,TheU.S.PreventiveServicesTaskForcer...
(Date:11/24/2009)...USPSTFRepresentationandRecommendationProcess ,...alsectionsofSenatehealthcarereformlegislation cont...rivateinsurers,MedicareandMedicaidwouldonlyberequi...S.PreventativeServicesTaskForce.Presently,thiswoul...requirecoverageofbiennial(everyotheryear)coveragef...
(Date:11/24/2009)...r 24, 2009 Researchers at Ben-Gurion University o...ts cancerous skin tumors, including melanomas that...al testing, the OSPI instrument (Optical Spectro-P...ons that have never been seen before - including m...s skin lesions and were awaiting surgery for their...
Breaking Medicine News(10 mins):Health News:Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger 2Health News:Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger 3Health News:Harm Reduction for Alcohol: An Idea Whose Time Has Arrived 2Health News:USPSTF Mammography Recommendations Should Be Specifically Excluded From Health Care Reform Legislation 2Health News:USPSTF Mammography Recommendations Should Be Specifically Excluded From Health Care Reform Legislation 3Health News:New device enables early detection of cancerous skin tumors -- Ben Gurion U. 2
...you to cast a ballot, study suggests , , T...polls on Nov. 4? If so, your genes may be driving...ch as 50 percent of whether you vote or not may be...an family political history. , "Both nature and nu...
...The following is a,statement by Christine James-Br...hat Congress has taken the authority and opportuni...nd Targeted Case Management,(TCM) rules, as well a...d and clear statement that it is wrong to,target t...
...frastructure Helps Spanish Health Administrator, ...ngoing IT Development ...Inc.,(Nasdaq: TIBX ) today announced that the hea...alud (SERIS) will link,together a range of applica...
... ETHICON, Inc., a Johnson &,Johnson company, toda...tional offer from One Equity Partners to acquire t...cted a competitive bidding process to,prepare for ...One Equity Partners. The Professional Wound Care b...
... The Compassionate Friends self-help support org...rieving process following the death of a child is ... Nashville, Tennessee. More than 1300 parents, sib...more than 100 workshops covering most aspects of g...
... Professional Services, Information Security and ...Class Framework, DALLAS, July 1 The Health Infor...at it is on target to deliver the first-ever,Commo...curity specialists, liability insurers and other,o...
Other Medicine News:Health News:Genes Get Out the Vote 2Health News:Genes Get Out the Vote 3Health News:Statement by Christine James-Brown, President and CEO, Child Welfare League of America (CWLA) Re: Moratorium on Medicaid Regulations 2Health News:Rioja Hospital Uses TIBCO Software to Improve Customer Care and Streamline Operations 2Health News:ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business 2Health News:ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business 3Health News:ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business 4Health News:Families Mourning Children Travel to Nashville for July Compassionate Friends National Conference 2Health News:HITRUST Confirms Release Date for First-Ever Common Security Framework for Electronic Health Information 2Health News:HITRUST Confirms Release Date for First-Ever Common Security Framework for Electronic Health Information 3Health News:HITRUST Confirms Release Date for First-Ever Common Security Framework for Electronic Health Information 4Health News:HITRUST Confirms Release Date for First-Ever Common Security Framework for Electronic Health Information 5
...oductivity, and proven reliability, Sorvall offers...g and centrifugation system that offers you a fast...e digital readouts, easy-to-operate touch controls...reliability, based on 40 years of proven performan...
MIC-D Digital Microscope
KR 4.22 Programmable Refrigerated Floor Model Centrifuge.
... programmable high and low speed refrigerated cent...LOCK JOUAN patented system, comprehensive control ..., Lifetime reproducibility, individual password pr... rates (100 run profiles), powerful refrigeration ...
Medicine Products: